Reactions Weekly

, Volume 1633, Issue 1, pp 67–67 | Cite as


Various toxicities: 3 case reports
Case report


  1. Saeki T, et al. Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. International Cancer Conference Journal 5: 178-182, No. 4, Oct 2016. Available from: URL: - Japan

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations